FDA Accepts Biogen Idec’s License Application for First Long-Lasting Factor Therapy for Hemophilia B
WESTON, Mass.-Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline. Recombinant FIXFc is the first product candidate in […]
CNN: Researchers Say Toddler Cured of HIV
(CNN) — It’s a potential game changer in the fight against HIV, and doctors say it happened almost by accident.A baby with the virus that causes AIDS was given high doses of three antiretroviral drugs within 30 hours of her birth. Doctors knew the mother was HIV positive and administered the drugs in hopes of […]